CHA Vaccine Research Institute (KOSDAQ:261780)
South Korea · Delayed Price · Currency is KRW 2,870.00
+100.00 (3.61%)
At close: Sep 17, 2025
KOSDAQ:261780 Revenue
CHA Vaccine Research Institute had revenue of 158.62M KRW in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 158.62M, down -57.21% year-over-year. In the year 2024, CHA Vaccine Research Institute had annual revenue of 370.66M with 26.02% growth.
Revenue (ttm)
158.62M
Revenue Growth
-57.21%
P/S Ratio
486.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
77.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 370.66M | 76.53M | 26.02% |
| Dec 31, 2023 | 294.12M | 114.64M | 63.87% |
| Dec 31, 2022 | 179.48M | -320.52M | -64.10% |
| Dec 31, 2021 | 500.00M | 422.20M | 542.70% |
| Dec 31, 2020 | 77.80M | -48.32M | -38.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |